Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study

Sitikantha Banerjee; Kajari Bandyopadhyay; Mubashshera F Khan; Sujiv Akkilagunta; Kalaiselvi Selvaraj; Jaya P Tripathy; Ranjan Solanki; Arvind S Kushwaha; Pradeep Deshmukh

doi:10.4103/jfmpc.jfmpc_503_19

Coverage of mass drug administration for elimination of lymphatic filariasis in urban Nagpur, Central India: A mixed method study

J Family Med Prim Care. 2019 Sep 30;8(9):3009-3014. doi: 10.4103/jfmpc.jfmpc_503_19. eCollection 2019 Sep.

Authors

Sitikantha Banerjee¹, Kajari Bandyopadhyay¹, Mubashshera F Khan¹, Sujiv Akkilagunta¹, Kalaiselvi Selvaraj¹, Jaya P Tripathy¹, Ranjan Solanki¹, Arvind S Kushwaha¹, Pradeep Deshmukh¹

Affiliation

¹ Department of Community Medicine, All India Institute of Medical Sciences, Nagpur, Maharashtra, India.

Abstract

Background and aims: Mass Drug Administration (MDA) coverage remains an important indicator in elimination of Lymphatic Filariasis (LF), especially in context of recent changes in programme strategies in India, such as incorporation of Ivermectin and involvement of urban Accredited Social Health Activists (ASHAs). This study aimed at assessing the coverage and compliance with MDA of Filariasis as well as exploring perspective of beneficiaries for non-consumption in selected slum area of Nagpur city.

Methods: Mixed-method study design comprising of quantitative assessment of MDA coverage, followed by qualitative method to explore the reasons of non-compliance was used in selected slum areas of Nagpur city. Using cluster sampling, 240 households were selected and house-to-house visits were made to interview the eligible participants. In-depth interviews were conducted among selected non-compliant participants.

Statistical analysis: Multivariable logistic regression analysis to identify the factors associated with non-consumption. Thematic analysis was done to obtain the reasons of non-consumption as perceived by the beneficiaries.

Results: Among the 1096 individuals studied, distribution and consumption coverage were 55.2% and 48.5%, respectively. Effective supervised consumption was further low (28.9%). Coverage compliance gap (CCG) was 12.1%. Male sex and younger age (2-5 years) were significant socio-demographic determinants of non-consumption. No repeat visit to houses left in first round, fear of side effects, pill burden, poor understanding about the need were important reasons as revealed by qualitative inquiry.

Conclusion: Effective pre-campaign awareness, incorporation of context specific drug delivery strategies and strengthening monitoring system are essential for successful MDA implementation.

Keywords: Ivermectin; lymphatic filariasis; mass drug administration; mixed-method; non-consumption.